Gossamer Bio Inc at Goldman Sachs Healthcare Conference Transcript
Okay. We'll continue with the next session. Hi, everyone. I'm Paul Choi, and I cover the small and mid-cap biotechnology sector here at Goldman Sachs. It's my pleasure to welcome Gossamer Bio for our final session of this afternoon. Joining us from the management team. To my immediate right is CMO, Richard Aranda; to my immediate left, CEO, Faheem Hasnain; and to my far left, CFO, Bryan Giraudo. What we'll do is let Faheem kick it off maybe with some introductory remarks, and then we'll get into questions. If anyone in the audience has questions along the way, please raise -- feel free to raise your hand, and we'll get a microphone to you. Also, if anyone listening in on the webcast has questions, please feel free to e-mail me, and we'll read them anonymously during the session. But with that, I'll turn it over to Faheem.
Yes. Thanks, Paul. So look, we're very excited about getting our Phase III off the ground.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
